SE Come

878 citations

19 papers · 694 · 1 hit paper · h-index 9

Impact in

Cancer Research top 10%
- Breast Cancer Treatment Studies
Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology

Papers in

Oncology 8
- Cancer Treatment and Pharmacology 3
- Cancer Risks and Factors 2
- Cancer survivorship and care 2
Pulmonary and Respiratory Medicine 6
- Advanced Breast Cancer Therapies 6

Co-authors: Richard Elledge (1 shared paper)S. Gertler (1 shared paper)Matthew J. Ellis (1 shared paper)John Pippen (1 shared paper)Isaiah W. Dimery (1 shared paper)C. Kent Osborne (1 shared paper)Stephen E. Jones (1 shared paper)Alan Webster (1 shared paper)
Journals: Cancer Research (8 papers)Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (2 papers)Annals of Oncology (2 papers)European Journal of Cancer (1 paper)
Partner nations: United States Israel Canada

In The Last Decade

SE Come

19 papers receiving 654 citations

SE Come's Hit Papers

align trajectories log scale

Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial 2002 · 500 citations

Peers

Countries citing papers authored by SE Come

Since Specialization

Citations

This map shows the geographic impact of SE Come's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SE Come with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SE Come more than expected).

Fields of papers citing papers by SE Come

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SE Come. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SE Come. The network helps show where SE Come may publish in the future.

Co-authors

The 25 scholars most cited alongside SE Come, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with SE Come Line = papers co-authored together SE Come links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Double-Blind, Randomized Trial Comparing the Efficacy and Tolerability of Fulvestrant Versus Anastrozole in Postmenopausal Women With Advanced Breast Cancer Progressing on Prior Endocrine Therapy: Results of a North American Trial Journal of Clinical Oncology ·C. Kent Osborne, John Pippen, Stephen E. Jones, L M Parker, Matthew J. Ellis, SE Come, S. Gertler, JR May, G. Burton, Isaiah W. Dimery, Alan Webster, Charles Morris, Richard Elledge, Aman U. Buzdar Hit paper breakdown →	2002	500
2	New agents and new medical treatments for advanced breast cancer. PubMed ·I. Craig Henderson, Daniel F. Hayes, SE Come, Jay R. Harris, George P. Canellos	1987	50
3	TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. Journal of Clinical Oncology ·SJ Isakoff, Paul E. Goss, Erica L. Mayer, Tiffany A. Traina, LA Carey, Karen J. Krag, H. S. Rugo, M. C. Liu, Vered Stearns, SE Come, Darrell R. Borger, C. A. Quadrino, Dianne M. Finkelstein, J. E. Garber, Patrick J. Ryan, Eric P. Winer, Leif W. Ellisen	2011	31
4	Sequencing of chemotherapy and radiation therapy for patients with early stage breast cancer: updated results of a prospective randomized trial International Journal of Radiation OncologyBiologyPhysics ·Jennifer R. Bellon, SE Come, Rebecca Gelman, I. Craig Henderson, L. Shulman, B. Silver, Jay R. Harris, Abram Recht	2001	28
5	Attitudes of patients with metastatic breast cancer toward research biopsies Annals of Oncology ·Davinia Seah, Sarah Scott, Julie Najita, Thomas H. Openshaw, Karen J. Krag, Elizabeth S. Frank, Jessica Sohl, Zsofia K. Stadler, Merrill Garrett, Stuart G. Silverman, Jeffrey Peppercorn, Eric P. Winer, SE Come, Nancy U. Lin	2013	24
6	P4-11-12: Molecular Phenotype of Breast Cancers in a Large Cohort of Young Women According to Time Interval Since Pregnancy. Cancer Research ·LC Collins, Shari Gelber, JD Marotti, K. L. Cole, Sandra Kereakoglow, KJ Ruddy, EF Brachtel, Lidia Schapira, SE Come, VF Borges, PJ Schedin, Erica T. Warner, EP Winer, Ann H. Partridge	2011	12
7	A phase II feasibility study of palbociclib in combination with adjuvant endocrine therapy for hormone receptor-positive invasive breast carcinoma Annals of Oncology ·Erica L. Mayer, Angela DeMichele, Hope S. Rugo, Kathy D. Miller, Adrienne G. Waks, SE Come, Therese M. Mulvey, Rinath Jeselsohn, Beth Overmoyer, Hao Guo, William T. Barry, Cynthia Huang Bartlett, María Koehler, Eric P. Winer, Harold J. Burstein	2019	12
8	ICI 182,780 (Faslodex™) versus anastrozole (Arimidex™) for the treatment of advanced breast cancer in postmenopausal women — prospective combined analysis of two multicenter trials European Journal of Cancer ·Anthony Howell, C. Kent Osborne, J.F.R. Robertson, S.E. Jones, L. Mauriac, M. Ellis, SE Come, Ignace Vergote, Aman U. Budzar, SZ Gertler	2001	10
9	14 Sequencing of chemotherapy (CT) and radiotherapy (RT) following conservative surgery (CS) for patients with early-stage breast cancer: Results of a randomized trial International Journal of Radiation OncologyBiologyPhysics ·Abram Recht, SE Come, Barbara Silver, Rebecca Gelman, D F Hayes, L. Shulman, I. Craig Henderson, Jay R. Harris	1995	8
10	Abstract GS6-06: Local therapy and quality of life outcomes in young women with breast cancer Cancer Research ·LS Dominici, Jianwen Hu, TA King, KJ Ruddy, RM Tamimi, J Peppercorn, Lidia Schapira, VF Borges, SE Come, E Warner, AH Partridge, SM Rosenberg	2019	3
11	Fertility concerns in young women with breast cancer: Results from a prospective cohort study. Journal of Clinical Oncology ·Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Elizabeth S. Ginsburg, Lidia Schapira, SE Come, ME Meyer, Eric P. Winer, A. H. Partridge	2011	3
12	Abstract P4-10-04: Employment trends in young women following a breast cancer diagnosis Cancer Research ·AH Partridge, SM Rosenberg, PS Rajagopal, KJ Ruddy, RM Tamimi, L Schapira, SE Come, V. Borges, Shari Gelber	2016	2
13	Adjuvant dose-dense doxorubicin-cyclophosphamide x 4 with or without bevacizumab is safe: no evidence of short-term changes in left ventricular ejection fraction. Cancer Research ·PG Morris, M Dickler, HL McArthur, TA Traina, Lincoln Godfrey, R. M. Steingart, H. S. Rugo, N.U. Lin, Beverly Moy, SE Come, S. Sugarman, Larry Norton, CA Hudis, Celeste Dang	2009	2
14	Prevalence and Predictors of Distress in Young Women with Newly Diagnosed Early Stage Breast Cancer. Cancer Research ·KJ Ruddy, Shari Gelber, Rulla M. Tamimi, Erica L. Mayer, Lidia Schapira, SE Come, M. M.M.M.D.E. Meyer, Eric P. Winer, Ann H. Partridge	2009	2
15	P4-11-10: Perceptions, Knowledge and Satisfaction with Contralateral Prophylactic Mastectomy among Young Women with Breast Cancer. Cancer Research ·MS Tracy, ME Meyer, Karen Sepucha, S. Gelber, J Hirshfield-Bartek, Susan L. Troyan, Monica Morrow, L Schapira, SE Come, EP Winer, AH Partridge	2011	2
16	Coping strategies in young women with breast cancer. Journal of Clinical Oncology ·Kathryn J. Ruddy, S. Gelber, RM Tamimi, Lidia Schapira, SE Come, ME Meyer, Eric P. Winer, A. H. Partridge	2010	2
17	Abstract PD5-06: Adjuvant palbociclib plus endocrine therapy for hormone receptor positive/HER2 negative breast cancer: A phase II feasibility study Cancer Research ·EL Mayer, A. DeMichele, H. Guo, KD Miller, HS Rugo, B Schneider, AG Waks, SE Come, Therese M. Mulvey, C Huang Bartlett, María Koehler, WT Barry, EP Winer, HJ Burstein	2018	1
18	Abstract S3-06: Emergence of constitutively active estrogen receptor mutations in advanced estrogen receptor positive breast cancer Cancer Research ·RM Jeselsohn, Roman Yelensky, Gilles Buchwalter, G. Frampton, Funda Meric‐Bernstam, M Cristofanilli, CL Arteaga, Justin M. Balko, L. Anne Gilmore, S J Schnitt, SE Come, Lajos Pusztai, Philip Stephens, VA Miller, Martin M. Brown	2013	1
19	A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. Journal of Clinical Oncology ·Tessa Cigler, M. J. Higgins, Jackie Szymonifka, A. H. Partridge, JA Ligibel, Dianne M. Finkelstein, SE Come, Patrick J. Ryan, Paul E. Goss	2011	1

About SE Come

SE Come is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Genetics, Cancer Research and Surgery, having authored 19 papers that have together received 694 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (5 papers), Estrogen and related hormone effects (3 papers), Cancer Genomics and Diagnostics (3 papers), BRCA gene mutations in cancer (3 papers), Cancer Treatment and Pharmacology (3 papers), Cancer Risks and Factors (2 papers) and Cancer survivorship and care (2 papers). The work is most often cited by research in Cancer Research (224 citations), Oncology (353 citations), Genetics (338 citations), Pulmonary and Respiratory Medicine (207 citations) and Pathology and Forensic Medicine (35 citations). SE Come has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Richard Elledge, S. Gertler, Matthew J. Ellis, John Pippen, Isaiah W. Dimery, C. Kent Osborne, Stephen E. Jones, Alan Webster, Charles Morris and L M Parker. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

SE Come

Impact in

Papers in i

In The Last Decade

SE Come

SE Come's Hit Papers

Peers

Countries citing papers authored by SE Come

Fields of papers citing papers by SE Come

All Works

About SE Come

Explore authors with similar magnitude of impact

Papers in